Young S, Kim Y, Woo K
Taiwan J Ophthalmol. 2025; 14(4):548-553.
PMID: 39803393
PMC: 11717341.
DOI: 10.4103/tjo.TJO-D-23-00043.
Kozaki A, Inoue R, Yaji N, Nishiyama K, Inoue T
Clin Ophthalmol. 2024; 18:2147-2154.
PMID: 39070106
PMC: 11277827.
DOI: 10.2147/OPTH.S456543.
Baeg J, Choi H, Kim C, Kim H, Jang S
Front Endocrinol (Lausanne). 2023; 13:1080204.
PMID: 36824601
PMC: 9941741.
DOI: 10.3389/fendo.2022.1080204.
Kozaki A, Nakamura H, Inoue T
Int Med Case Rep J. 2018; 11:325-331.
PMID: 30519121
PMC: 6233704.
DOI: 10.2147/IMCRJ.S177671.
Kang H, Takahashi Y, Iwaki M, Asamura S, Kakizaki H
Clin Ophthalmol. 2012; 6:807-10.
PMID: 22701081
PMC: 3373229.
DOI: 10.2147/OPTH.S29408.
Double motion of upper eyelids in Graves' orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies.
Kakizaki H, Takahashi Y, Iwaki M, Ichinose A, Selva D, Leibovitch I
Clin Ophthalmol. 2011; 5:327-30.
PMID: 21468341
PMC: 3065575.
DOI: 10.2147/OPTH.S17572.
Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).
Kikkawa D
Trans Am Ophthalmol Soc. 2011; 108:46-61.
PMID: 21212848
PMC: 3016081.
Thyroid-associated orbitopathy.
Alsuhaibani A, Nerad J
Semin Plast Surg. 2010; 21(1):65-73.
PMID: 20567660
PMC: 2884831.
DOI: 10.1055/s-2007-967751.
Eyelid malpositions in Graves' ophthalmopathy.
Waller R
Trans Am Ophthalmol Soc. 1982; 80:855-930.
PMID: 6897828
PMC: 1312285.
Graves' eye disease: orbital compliance and other physical measurements.
Frueh B
Trans Am Ophthalmol Soc. 1984; 82:492-598.
PMID: 6398935
PMC: 1298676.
Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.
CROMBIE A, Lawson A
Br Med J. 1967; 4(5579):592-5.
PMID: 6060118
PMC: 1749317.
DOI: 10.1136/bmj.4.5579.592.
Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.
CANT J, Lewis D
Br J Ophthalmol. 1969; 53(4):239-45.
PMID: 5818670
PMC: 1207306.
DOI: 10.1136/bjo.53.4.239.
Use of guanethidine eye drops in dysthyroid lid retraction.
Martin B, Jay B
Proc R Soc Med. 1969; 62(1):18-9.
PMID: 5763459
PMC: 2279078.
Management of endocrine ophthalmopathy.
Br Med J. 1968; 3(5618):565-6.
PMID: 5667981
PMC: 1991119.
[The extra-renal ocular complications of diabetes mellitus. Current concepts of pathogenesis and management].
RECORDS R
Acta Diabetol Lat. 1970; 7(5):709-59.
PMID: 4949514
DOI: 10.1007/BF01556815.
Dysthyroid eye disease. A trial of guanethidine eye drops.
Bowden A, ROSE F
Br J Ophthalmol. 1969; 53(4):246-51.
PMID: 4889097
PMC: 1207307.
DOI: 10.1136/bjo.53.4.246.
Adrenergic blocking agents. A double-blind trial in the treatment of the eye signs of thyroid disorders.
CROMBIE A, Lawson A
Br J Ophthalmol. 1968; 52(8):616-20.
PMID: 4881690
PMC: 506653.
DOI: 10.1136/bjo.52.8.616.
Upper eyelid retraction in Graves' ophthalmopathy: a new surgical technique and a study of the abnormal levator muscle.
SMALL R
Trans Am Ophthalmol Soc. 1988; 86:725-93.
PMID: 2979032
PMC: 1298826.
The human pupil as a model for clinical pharmacological investigations.
Turner P
J R Coll Physicians Lond. 1975; 9(2):165-71.
PMID: 236382
PMC: 5366498.
